Skip to content

Population Screening Using Smartphone in Milpa Alta

Massive Mental Health Screening Using Smartphone in Milpa Alta Community, Mexico.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04067063
Acronym
Smart-screen
Enrollment
150000
Registered
2019-08-26
Start date
2019-08-26
Completion date
2021-04-30
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abuse, Anxiety, Depression, Depressive Disorder, Drug Abuse, Suicidal Ideation

Keywords

Mass Screening, Health Surveys, Mental Health, Suicidal Ideation

Brief summary

The objective of this study is to make a suicide screening in the entire population of Milpa Alta (approximately 150,000 inhabitants), taking into account other outcomes such as depression, anxiety, alcohol and drugs. For this, an app for Smartphone (MeMind) or a web platform (www.MeMind.net) will be used in which the participants will take a self-administered questionnaire, composed of several psychometric instruments . It is expected that 70% of the population between 15 and 70 years old can do so directly with their own Smartphone, although web access posts will be enabled in educational and municipal units to avoid discrimination based on age or access to technology. Our main hypothesis argues that the early identification of people at risk in almost the entire community can be done with an App for Smartphone, serving to depict a map of mental health and related needs of the population, serving for the planning of healthcare services of the local environment, and ultimately for the best assistance of groups and individuals with greater needs through their identification and early reference to medical assistance.

Interventions

Smartphone app with MeMind questionnaires

Sponsors

Universidad Nacional Autonoma de Mexico
CollaboratorOTHER
Milpa Alta Municipalty
CollaboratorUNKNOWN
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
CollaboratorOTHER_GOV
Centro Interdisciplinario de Ciencias de la Salud, Mexico
CollaboratorUNKNOWN
Educational Institutions of Milpa Alta
CollaboratorUNKNOWN
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
15 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Use a smartphone as personal or computer terminals enabled by the municipality of Milpa Alta or educational services. 2. Be able to understand the nature, purpose and methodology of the study. 3. Accept participation in the study and check the corresponding box in the app to verify that the informed consent has been expressly given.

Exclusion criteria

1. Subject deprived of liberty (by judicial or administrative decision) 2. Subject protected by law (guardianship or conservatorship)

Design outcomes

Primary

MeasureTime frameDescription
Suicidal ideation1 DayColumbia-Suicide Severity Rating Scale (C-SSRS) is encompassed into MeMind for this purpose. In C-SSRS, four constructs are measured. The first is the severity of ideation, which is rated on a 5-point ordinal scale from 1=wish to be dead to 5=suicidal intent with plan. The second is the intensity of ideation, which comprises 5 items, each rated on a 5-point ordinal scale: frequency, duration, controllability, deterrents, and reason for ideation. The third is the behavior, which is rated on a nominal scale that includes actual, aborted, and interrupted attempts; preparatory behavior; and nonsuicidal self-injurious behavior. And the fourth is the lethality, which assesses actual attempts; actual lethality is rated on a 6-point ordinal scale. Results are coded in the instrument itself with colored labels that indicates definitions of suicidal ideation and behavior, quantify both of them and gauge their severity. Definitions are available elsewhere (http://cssrs.columbia.edu).

Secondary

MeasureTime frameDescription
Depression1 DayParticipants will be asked to complete a questionnaire regarding possible symptoms related to depression. PHQ-9 questionnaire is emcompassed into Memind for this purpose.
Anxiety1 DayParticipants will be asked to complete a questionnaire regarding possible symptoms related to anxiety. GAD-7 (only screening questions) is emcompassed into Memind for this purpose.
Drug Utilization1 DayParticipants will be asked to complete a questionnaire regarding possible symptoms related to anxiety. DAST (only questions 1,6,7) is emcompassed into Memind for this purpose.
Alcohol Drinking1 DayParticipants will be asked to complete a questionnaire regarding possible symptoms related to alcohol abuse. Alcohol Use Disorders Identification Test (AUDIT-C)

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026